ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
valueadd
|
216 |
66K |
5 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
216
|
66K
|
5
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS Awarded $466,840 Contract from Penten
|
|
valueadd
|
9 |
2.2K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
9
|
2.2K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
21K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
21K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
21K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
21K
|
0
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
21K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
21K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
valueadd
|
23K |
11M |
33 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
23K
|
11M
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
valueadd
|
23K |
11M |
10 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
23K
|
11M
|
10
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
21K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
107
|
21K
|
2
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
21K |
5 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
107
|
21K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
valueadd
|
216 |
95K |
24 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
216
|
95K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
valueadd
|
303 |
121K |
6 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
303
|
121K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
62K |
15 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
163
|
62K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
62K |
12 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
62K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
62K |
28 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
62K
|
28
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
62K |
9 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
62K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
valueadd
|
163 |
62K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
62K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
valueadd
|
106 |
34K |
8 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
34K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
valueadd
|
106 |
34K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
34K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
valueadd
|
422 |
146K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
422
|
146K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
28K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
85
|
28K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
28K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
85
|
28K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
valueadd
|
106 |
34K |
11 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
34K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
valueadd
|
106 |
34K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
34K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
28K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
85
|
28K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
28K |
15 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
85
|
28K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is NOT a MULTI Bagger is a BAGGIES company
|
|
valueadd
|
85 |
28K |
35 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
85
|
28K
|
35
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
valueadd
|
303 |
121K |
17 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
121K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
valueadd
|
303 |
121K |
49 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
121K
|
49
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.3M |
16 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
13K
|
6.3M
|
16
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
valueadd
|
2.8K |
836K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
2.8K
|
836K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Oncolytic Virotherapy CF33 Patent Granted in China
|
|
valueadd
|
118 |
56K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
118
|
56K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
valueadd
|
216 |
95K |
9 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
216
|
95K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.3M |
12 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
13K
|
6.3M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.3M |
2 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.3M |
17 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
13K
|
6.3M
|
17
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
valueadd
|
107 |
21K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
107
|
21K
|
3
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
valueadd
|
2.8K |
836K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
2.8K
|
836K
|
1
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
35K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
169
|
35K
|
0
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
valueadd
|
2.8K |
836K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
2.8K
|
836K
|
3
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
valueadd
|
2.8K |
836K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
2.8K
|
836K
|
3
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
35K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
169
|
35K
|
0
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
35K |
0 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
169
|
35K
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
valueadd
|
32K |
15M |
12 |
22/03/24 |
22/03/24 |
Charts
|
32K
|
15M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.3M |
13 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
13K
|
6.3M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
|
|
valueadd
|
30 |
18K |
46 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
30
|
18K
|
46
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
35K |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
169
|
35K
|
0
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
35K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
169
|
35K
|
1
|
|
ASX - By Stock
|
PIL |
Re:
Ann: Explanatory note, Top 20 and Appendix 2A
|
|
valueadd
|
169 |
35K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
169
|
35K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
valueadd
|
13K |
6.3M |
7 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
13K
|
6.3M
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Half Yearly Report and Accounts
|
|
valueadd
|
17 |
4.6K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
17
|
4.6K
|
2
|
|